Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer

Overview of attention for article published in OncoTargets and therapy, May 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells – Implications for systemic control

Article in Radiotherapy and Oncology (January 2024)

A “scoping” review of prostate brachytherapy and immune responses

Article in Brachytherapy (November 2022)

Traditional Chinese medicine CFF-1 exerts a potent anti-tumor immunity to hinder tumor growth and metastasis in prostate cancer through EGFR/JAK1/STAT3 pathway to inhibit PD-1/PD-L1 checkpoint signaling

Article in Phytomedicine (January 2022)